Mesenchymal stromal cells isolated from human fetal liver release soluble factors with a potential role in liver tissue repair

2019 ◽  
Vol 105 ◽  
pp. 14-26 ◽  
Author(s):  
Cinzia Maria Chinnici ◽  
Giada Pietrosi ◽  
Gioacchin Iannolo ◽  
Giandomenico Amico ◽  
Nicola Cuscino ◽  
...  
2020 ◽  
Vol 22 (4) ◽  
pp. 33-36
Author(s):  
I. E. Kotkas ◽  
V. I. Masurov ◽  
I. G. Bakulin ◽  
N. I. Enukashvili ◽  
Sh. M. Asadulayev

Clinical experience of application of autologous multipotent mesenchymal stromal cells in treatment of patient suffering from liver cirrhosis of alcoholic etiology is presented. A special feature is that the hepatocyte precursors were isolated directly from the patients liver tissue. The patient underwent laparoscopic surgery to obtain the largest volume of material and to be able to visually control the tissue sampling with minimal fibrotic changes. After liver tissue sampling, the patient was discharged for outpatient treatment in a satisfactory condition. Subsequently, the patient was re-admitted to the hospital. During repeated hospitalization, multipotent mesenchymal stromal cells in the amount of 20 million were injected into the arterial bed of the liver using x-ray endovascular technique. In the control study, 6 months after treatment, according to the 13C-metacetin test, normalization of liver function, regression of portal hypertension, and an increase in platelet levels were noted. There were no complications during this treatment. Treatment of patients suffering from cirrhosis of the liver is quite a serious and complex task. As a rule, the patient learns about his diagnosis already in the presence of complications, when the liver function is already significantly impaired. The propensity of the population to alcoholism leads to the formation of fibrosis, and subsequently cirrhosis of the liver. The absence of anti-fibrotic drugs contributes to the implementation of research to find alternative methods of treatment for this category of patients. In General, the use of autologous multipotent mesenchymal stromal cells is an effective and promising method, and research in this direction should be continued.


2017 ◽  
Vol 7 ◽  
Author(s):  
Danilo Candido de Almeida ◽  
Ênio Jose Bassi ◽  
Hatylas Azevedo ◽  
Letícia Anderson ◽  
Clarice Silvia Taemi Origassa ◽  
...  

2019 ◽  
Vol 130 (1) ◽  
Author(s):  
Srinivasa Rao Nagubothu ◽  
Rachael V. Sugars ◽  
Nikolce Tudzarovski ◽  
Anton Törnqvist Andrén ◽  
Matteo Bottai ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-15 ◽  
Author(s):  
Leah A. Marquez-Curtis ◽  
Anna Janowska-Wieczorek

Mesenchymal stromal cells (MSCs) are currently being investigated in numerous clinical trials of tissue repair and various immunological disorders based on their ability to secrete trophic factors and to modulate inflammatory responses. MSCs have been shown to migrate to sites of injury and inflammation in response to soluble mediators including the chemokine stromal cell-derived factor-(SDF-)1, but during in vitro culture expansion MSCs lose surface expression of key homing receptors particularly of the SDF-1 receptor, CXCR4. Here we review studies on enhancement of SDF-1-directed migration of MSCs with the premise that their improved recruitment could translate to therapeutic benefits. We describe our studies on approaches to increase the CXCR4 expression in in vitro-expanded cord blood-derived MSCs, namely, transfection, using the commercial liposomal reagent IBAfect, chemical treatment with the histone deacetylase inhibitor valproic acid, and exposure to recombinant complement component C1q. These methodologies will be presented in the context of other cell targeting and delivery strategies that exploit pathways involved in MSC migration. Taken together, these findings indicate that MSCs can be manipulated in vitro to enhance their in vivo recruitment and efficacy for tissue repair.


Cytotherapy ◽  
2012 ◽  
Vol 14 (6) ◽  
pp. 657-669 ◽  
Author(s):  
Meghnad Joshi ◽  
Pradeep B. Patil ◽  
Zhong He ◽  
Jan Holgersson ◽  
Michael Olausson ◽  
...  

2016 ◽  
Vol 55 (1) ◽  
pp. 62-69 ◽  
Author(s):  
Jillian Stephen ◽  
Elena Lopez Bravo ◽  
David Colligan ◽  
Alasdair R. Fraser ◽  
Juraj Petrik ◽  
...  

Hepatology ◽  
1993 ◽  
Vol 17 (2) ◽  
pp. 225-229 ◽  
Author(s):  
Fuchu He ◽  
Chutse Wu ◽  
Qiang Tu ◽  
Guichun Xing

Cytotherapy ◽  
2016 ◽  
Vol 18 (7) ◽  
pp. 846-859 ◽  
Author(s):  
Bruno Sangiorgi ◽  
Helder Teixeira De Freitas ◽  
Josiane Lilian Dos Santos Schiavinato ◽  
Vitor Leão ◽  
Rodrigo Haddad ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document